berberine has been researched along with Alveolar Bone Atrophy in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Gan, J; Gu, L; Ke, Y; Li, X | 1 |
Chen, V; Guo, Q; He, J; Jia, L; Jia, X; Mo, L; Xu, X; Yuan, Q; Yuan, S; Zheng, L; Zheng, X; Zhou, X | 1 |
2 other study(ies) available for berberine and Alveolar Bone Atrophy
Article | Year |
---|---|
Berberine suppresses bone loss and inflammation in ligature-induced periodontitis through promotion of the G protein-coupled estrogen receptor-mediated inactivation of the p38MAPK/NF-κB pathway.
Topics: Alveolar Bone Loss; Animals; Berberine; Inflammation; MAP Kinase Signaling System; p38 Mitogen-Activated Protein Kinases; Periodontitis; Rats; Receptors, Estrogen; Receptors, G-Protein-Coupled; Transcription Factor RelA; X-Ray Microtomography | 2021 |
Berberine Ameliorates Periodontal Bone Loss by Regulating Gut Microbiota.
Topics: Alveolar Bone Loss; Animals; Berberine; Butyrates; Female; Gastrointestinal Microbiome; Humans; Osteoporosis, Postmenopausal; Ovariectomy; Periodontitis; Phytotherapy; Plant Extracts; Plants, Medicinal; Rats; RNA, Ribosomal, 16S; X-Ray Microtomography | 2019 |